Caption Management, LLC Exact Sciences Corp Transaction History

Caption Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$41.33 - $74.26 $644,748 - $1.16 Million	15,600 New	15,600 $659,000
Q4 2023 Feb 14, 2024	BUY	$59.06 - $75.72 $125,207 - $160,526	2,120 Added 184.83%	3,267 $241,000
Q3 2023 Nov 14, 2023	BUY	$65.94 - $99.04 $75,633 - $113,598	1,147 New	1,147 $78,000
Q1 2023 May 15, 2023	SELL	$47.19 - $70.77 $4.76 Million - $7.14 Million	-100,883 Reduced 61.29%	63,712 $4.32 Million
Q4 2022 Feb 14, 2023	BUY	$30.35 - $53.15 $436,888 - $765,094	14,395 Added 9.58%	164,595 $8.15 Million
Q3 2022 Nov 14, 2022	BUY	$31.97 - $49.37 $4.64 Million - $7.16 Million	145,000 Added 2788.46%	150,200 $4.88 Million
Q2 2022 Aug 15, 2022	BUY	$35.61 - $76.23 $181,646 - $388,849	5,101 Added 5152.53%	5,200 $205,000
Q1 2022 May 13, 2022	SELL	$57.56 - $82.54 $1,036 - $1,485	-18 Reduced 15.38%	99 $7,000
Q4 2021 Feb 11, 2022	SELL	$72.5 - $100.68 $317,767 - $441,280	-4,383 Reduced 97.4%	117 $10,000
Q3 2020 Nov 16, 2020	SELL	$72.92 - $102.01 $10.1 Million - $14.1 Million	-138,600 Reduced 96.86%	4,500 $459,000
Q4 2018 Jan 30, 2019	BUY	$56.04 - $82.66 $8.02 Million - $11.8 Million	143,100 New	143,100 $9.03 Million

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.